isoxsuprine has been researched along with HbS Disease in 4 studies
Isoxsuprine: A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.
Excerpt | Relevance | Reference |
---|---|---|
"Isoxsuprine was administered in 3 successive steps: (1) as an IM injection (5-10 mg), (2) as a rapid IV infusion (1 mg/minute), and (3) as a slow, continuous IV infusion, (0." | 1.26 | Experience with isoxsuprine in the treatment of sickle cell crisis: a proposed mechanism of action. ( Bourantas, C; Kallerghi, G; Papageorgiou, J; Psomadakis, C, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MartÃ-Carvajal, AJ | 2 |
Knight-Madden, JM | 2 |
Martinez-Zapata, MJ | 2 |
Psomadakis, C | 1 |
Kallerghi, G | 1 |
Bourantas, C | 1 |
Papageorgiou, J | 1 |
Serjeant, GR | 1 |
Howard, C | 1 |
2 reviews available for isoxsuprine and HbS Disease
Article | Year |
---|---|
Interventions for treating leg ulcers in people with sickle cell disease.
Topics: Actihaemyl; Anemia, Sickle Cell; Anti-Bacterial Agents; Arginine; Bandages; Butyrates; Carnitine; Hu | 2014 |
Interventions for treating leg ulcers in people with sickle cell disease.
Topics: Actihaemyl; Anemia, Sickle Cell; Anti-Bacterial Agents; Arginine; Bandages; Butyrates; Carnitine; Hu | 2012 |
1 trial available for isoxsuprine and HbS Disease
Article | Year |
---|---|
Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration.
Topics: Anemia, Sickle Cell; Clinical Trials as Topic; Drug Evaluation; Isoxsuprine; Leg Ulcer | 1977 |
1 other study available for isoxsuprine and HbS Disease
Article | Year |
---|---|
Experience with isoxsuprine in the treatment of sickle cell crisis: a proposed mechanism of action.
Topics: Anemia, Sickle Cell; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, I | 1981 |